(Q54831032)

English

DFCI024

cell line

DFCI 024
DFCI.024
Dana-Farber Cancer Institute 024

In more languages

Statements

1 reference

Cellosaurus release 44

7 January 2023

cancer cell line

1 reference

Cellosaurus release 44

7 January 2023

described by source

EML4-ALK fusion gene and efficacy of an ALK kinase inhibitor in lung cancer

1 reference

Cellosaurus release 44

7 January 2023

Lung cancer cell lines as tools for biomedical discovery and research

1 reference

Cellosaurus release 44

7 January 2023

Characterization of Human Cancer Cell Lines by Reverse-phase Protein Arrays

1 reference

Cellosaurus release 44

7 January 2023

Immunoproteasome deficiency is a feature of non-small cell lung cancer with a mesenchymal phenotype and is associated with a poor outcome.

1 reference

Cellosaurus release 44

7 January 2023

Next-generation characterization of the Cancer Cell Line Encyclopedia

1 reference

Cellosaurus release 44

7 January 2023

Chemistry-First Approach for Nomination of Personalized Treatment in Lung Cancer.

1 reference

Cellosaurus release 44

7 January 2023

established from medical condition

adenocarcinoma of the lung

1 reference

Cellosaurus release 44

7 January 2023

derived from organism type

1 reference

Cellosaurus release 44

7 January 2023

Identifiers

1 reference

Cellosaurus release 44

7 January 2023

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q54831032&oldid=1861298229"